ClickCease
Menu
08/27/06   |   By

New Test Predicts Lung Cancer Risk of Spread | DC Metro Area Medical Malpractice Law Blog

5 stars

Scientists at Duke University have developed a new test, called the Lung Metagene Predictor, which is able to predict with near certainty whether the most common type of lung cancer will return after surgery. The 90% accurate predictions allow physicians to better prescribe a treatment for the patient.

Lung cancer is either classified as “small-cell” or “non-small-cell.” The small-cell cancer is treated with chemotherapy and non-small-cell is usually treated with surgery. However, nearly one-third of those patients who undergo surgery see a reappearance of the cancer in their bodies. The Lung Metagene Predictor will allow physicians to determine which patients will see the reappearance and prescribe a more aggressive treatment for them.

Duke researcher David Harpole says, “If we can use the test to increase patient survival by even 5 percent, we would save 10,000 lives a year. In reality, we can do much better than that.”

Regan Zambri Long
Posted In
Uncategorized
Share This Article

Schedule a Free Consultation

Have you or your loved one sustained injuries in Washington DC, Maryland or Virginia? Regan Zambri Long PLLC has the best lawyers in the country to analyze your case and answer the questions you may have.

Call 202-960-4596

  • Please do not send any confidential or sensitive information in this form. This form sends information by non-encrypted email, which is not secure. Submitting this form does not create an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.

Back to Top